RxDoctor Payments Data

Eliathamby Kuganeswaran, MD

Gastroenterology · Peoria, ILNPI 1073555488

Payments from drug & device makers

$7,440in general payments, 2019–2025

Across 489 payments — averaging $15.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Takeda Pharmaceuticals U.S.A., Inc.$828
  • Johnson & Johnson$649
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$361
  • Merck$335
  • Bristol Myers Squibb$285
  • plus $1K from 25 others

What the payments were for

  • Food & beverage$7,31898%
  • Education$1222%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,440 in reported general payments places this provider in the 75th percentile of 787 gastroenterology providers in Illinois.

See all gastroenterology providers in Illinois

Medicare billing

Part B allowed, 2024
$230,738
Medicare patients
537
Services billed
6,862

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi On-BodyRisankizumab-Rzaa20$407,938
StelaraUstekinumab12$291,830
Humira(Cf) PenAdalimumab12$82,557
CreonLipase/Protease/Amylase16$44,541
Mesalamine34$26,065
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates215$14,546
PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C40$5,832
Budesonide EcBudesonide13$4,938
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl158$2,908
Ursodiol20$2,834
SutabSod Sulf/Pot Chloride/Mag Sulf12$1,951
Rabeprazole Sodium66$1,703
Dexlansoprazole DrDexlansoprazole11$1,367
Omeprazole153$1,202
Colestipol Hcl14$1,026

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonStelara$649$291,83012 claims
AbbVieCreon$3,699$44,54116 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCPlenvu$361$5,83240 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 787 gastroenterology providers in Illinois.

Other gastroenterology in Peoria

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →